Tiziana Life Sciences Stock News

NEW YORK , March 10, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TLSA, INDO, USWS, KALA, and NINE. … Full story available on Benzinga.com

Tiziana Life Sciences ((TLSA)) reported positive data from a patient with Secondary Progressive Multiple Sclerosis ((SPMS)) treated for six months with intranasally…

Penny stocks are on the move today with some of the top companies in the space seeing major movement alongside heavy trading of their shares. The post Top Penny Stocks Today: Why PT, TLSA, AGRI and HT

NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.’s (Nasdaq: TLSA) former subsidiary, AccuStem Sciences, Inc. (OTC PINK: ACMSY) (formerly AccuStem Sciences Ltd.), today annou

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel rou

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel route

- Tiziana is Developing the First Oral Form of Foralumab in a Convenient Capsule to be Evaluated in Phase 1b Clinical Study

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) announced that its Board of Directors has today authorized the Company’s management to implement a stock repur

Tiziana Life Sciences Ltd announced that the US Food and Drugs Administration (FDA) has accepted its request to enroll a second patient onto the ongoing clinical treatment of secondary progressive mul

NEW YORK, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, tod

NEW YORK, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today

Will a lower price attract more investors? The answer is surprising.

Tiziana Life Sciences PLC (LON:TILS) shares crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 56.27 ($0.75) and traded as high as GBX 59 ($0.78). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.78), with a volume of 297,128 shares trading []

Tiziana Life Sciences PLC (NASDAQ:TLSA) saw a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 215,500 shares, a decrease of 25.4% from the October 31st total of 289,000 shares. Based on an average trading volume of 395,000 shares, the short-interest ratio is currently 0.5 []

Geode Capital Management LLC boosted its holdings in Tiziana Life Sciences PLC (NASDAQ:TLSA) by 469.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 84,581 shares of the companys stock after buying an additional 69,729 shares during the period. Geode Capital Management LLC [] The post Geode Capital Management LLC Grows Stock Holdings in Tiziana Life Sciences PLC (NASDAQ:TLSA) appeared first on ETF Daily News .